- Home
- AXTA vs XENE Comparison
AXTA vs XENE Comparison
Compare AXTA & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXTA | XENE |
|---|---|---|
| Founded | 1910 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Paints/Coatings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 5.2B |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | AXTA | XENE |
|---|---|---|
| Price | $30.35 | $53.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 11 |
| Target Price | $35.23 | ★ $68.55 |
| AVG Volume (30 Days) | ★ 2.2M | 960.6K |
| Earning Date | 04-30-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | ★ $5,117,000,000.00 | $311,000.00 |
| Revenue This Year | $3.60 | N/A |
| Revenue Next Year | $3.26 | $2,496.48 |
| P/E Ratio | $72.20 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $24.94 | $28.19 |
| 52 Week High | $35.72 | $62.91 |
Technical Indicators
Market Signals| Indicator | AXTA | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 61.95 | 43.18 |
| Support Level | $26.72 | $52.90 |
| Resistance Level | $30.89 | $59.43 |
| Average True Range (ATR) | 0.89 | 1.48 |
| MACD | 0.30 | -0.20 |
| Stochastic Oscillator | 73.79 | 26.08 |
Price Performance
Historical ComparisonAbout AXTA Axalta Coating Systems Ltd.
Axalta Coating Systems Ltd is a manufacturer, marketer, and distributor of high-performance coatings systems. It operates in two segments: Performance Coatings and Mobility Coatings. The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial, and the Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The majority of its revenue is generated from the Mobility Coatings segment. Geographically, the company generates maximum revenue from the Europe, Middle East and Africa (EMEA) region, followed by North America, Asia Pacific, and Latin America.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.